PAFAH1B2 and hepatocellular carcinoma: So, we did not continue to study the role of PAFAH1B2 in HCC, but our results showed that both PAFAH1B2 and PAFAH1B3 inhibition could have better effector than PAFAH1B3 siRNA in Huh7 cells.